Anna Lebedeva1, Daria Vorobyeva1, Murad Vagida1, Oxana Ivanova1, Eugeny Felker1, Wendy Fitzgerald2, Natalya Danilova3, Vladimir Gontarenko4, Alexander Shpektor1, Elena Vasilieva5, Leonid Margolis2. 1. Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia. 2. Section on Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. 3. Department of Clinical Pathology, Lomonosov Moscow State University, Moscow, Russia. 4. Department of Vascular Surgery, A.V. Vishnevsky Institute of Surgery, Moscow, Russia. 5. Laboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, Russia. Electronic address: vasilieva.helena@gmail.com.
Abstract
BACKGROUND AND AIMS: The mechanisms that drive atherosclerotic plaque progression and destabilization in humans remain largely unknown. Laboratory models are needed to study these mechanisms under controlled conditions. The aim of this study was to establish a new ex vivo model of human atherosclerotic plaques that preserves the main cell types in plaques and the extracellular components in the context of native cytoarchitecture. METHODS: Atherosclerotic plaques from carotid arteries of 28 patients undergoing carotid endarterectomy were dissected and cultured. At various time-points, samples were collected and analysed histologically. After enzymatic digestion, single cells were analysed with flow cytometry. Moreover, tissue cytokine production was evaluated. RESULTS: We optimised the plaque dissection protocol by cutting plaques into circular segments that we cultured on collagen rafts at the medium-air interface, thus keeping them well oxygenated. With this technique, the relative presence of T and B lymphocytes did not change significantly during culture, and the sizes of lymphocyte subsets remained stable after day 4 of culture. Macrophages, smooth muscle cells, and fibroblasts with collagen fibres, as well as T and B lymphocyte subsets and CD16 natural killer cells, remained largely preserved for 19 days of culture, with a continuous production of inflammatory cytokines and chemokines. CONCLUSIONS: Our new model of ex vivo human atherosclerotic plaques, which preserves the main subsets of immune cells in the context of tissue cytoarchitecture, may be used to investigate important aspects of atherogenesis, in particular, the functions of immune cells under controlled laboratory conditions.
BACKGROUND AND AIMS: The mechanisms that drive atherosclerotic plaque progression and destabilization in humans remain largely unknown. Laboratory models are needed to study these mechanisms under controlled conditions. The aim of this study was to establish a new ex vivo model of humanatherosclerotic plaques that preserves the main cell types in plaques and the extracellular components in the context of native cytoarchitecture. METHODS:Atherosclerotic plaques from carotid arteries of 28 patients undergoing carotid endarterectomy were dissected and cultured. At various time-points, samples were collected and analysed histologically. After enzymatic digestion, single cells were analysed with flow cytometry. Moreover, tissue cytokine production was evaluated. RESULTS: We optimised the plaque dissection protocol by cutting plaques into circular segments that we cultured on collagen rafts at the medium-air interface, thus keeping them well oxygenated. With this technique, the relative presence of T and B lymphocytes did not change significantly during culture, and the sizes of lymphocyte subsets remained stable after day 4 of culture. Macrophages, smooth muscle cells, and fibroblasts with collagen fibres, as well as T and B lymphocyte subsets and CD16 natural killer cells, remained largely preserved for 19 days of culture, with a continuous production of inflammatory cytokines and chemokines. CONCLUSIONS: Our new model of ex vivo humanatherosclerotic plaques, which preserves the main subsets of immune cells in the context of tissue cytoarchitecture, may be used to investigate important aspects of atherogenesis, in particular, the functions of immune cells under controlled laboratory conditions.
Authors: M F van Buul-Wortelboer; H J Brinkman; K P Dingemans; P G de Groot; W G van Aken; J A van Mourik Journal: Exp Cell Res Date: 1986-01 Impact factor: 3.905
Authors: D C MacLeod; B H Strauss; M de Jong; J Escaned; V A Umans; R J van Suylen; A Verkerk; P J de Feyter; P W Serruys Journal: J Am Coll Cardiol Date: 1994-01 Impact factor: 24.094
Authors: Christian Erbel; Deniz Okuyucu; Mohammadreza Akhavanpoor; Li Zhao; Susanne Wangler; Maani Hakimi; Andreas Doesch; Thomas J Dengler; Hugo A Katus; Christian A Gleissner Journal: J Vis Exp Date: 2014-05-06 Impact factor: 1.355
Authors: Jérôme Robert; Benedikt Weber; Laura Frese; Maximilian Y Emmert; Dörthe Schmidt; Arnold von Eckardstein; Lucia Rohrer; Simon P Hoerstrup Journal: PLoS One Date: 2013-11-14 Impact factor: 3.240
Authors: Bennett G Childs; Cheng Zhang; Fahad Shuja; Ines Sturmlechner; Shawn Trewartha; Raul Fierro Velasco; Darren Baker; Hu Li; Jan M van Deursen Journal: Nat Aging Date: 2021-08-02
Authors: Selim Demirdelen; Philip Z Mannes; Ali Mubin Aral; Joseph Haddad; Steven A Leers; Delphine Gomez; Sina Tavakoli Journal: J Nucl Cardiol Date: 2021-01-08 Impact factor: 3.872
Authors: Anna Garcia-Sabaté; Walaa Kamal E Mohamed; Jiranuwat Sapudom; Aseel Alatoom; Layla Al Safadi; Jeremy C M Teo Journal: Bioengineering (Basel) Date: 2020-09-16
Authors: Daria M Potashnikova; Aleena A Saidova; Anna V Tvorogova; Alexandra S Anisimova; Alexandra Yu Botsina; Elena Yu Vasilieva; Leonid B Margolis Journal: Front Med (Lausanne) Date: 2022-07-13